Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-04-27

Clinical Trial Update: Hub and Spoke, Comparative Outcomes for Parkinson's Disease Treated With Deep Brain Stimulation [NA]

View source ↗

Summary

The clinical trial NCT02541617 investigating hub-and-spoke deep brain stimulation for Parkinson's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vanderbilt University | Conditions: Parkinson's Disease | NA | Status: WITHDRAWN